Maja V Maraldo1, Michael Lundemann2, Ivan R Vogelius2, Lena Specht3. 1. Department of Oncology, Section of Radiotherapy, Rigshospitalet, University of Copenhagen, Denmark. Electronic address: dra.maraldo@gmail.com. 2. Department of Oncology, Section of Radiotherapy, Rigshospitalet, University of Copenhagen, Denmark. 3. Department of Oncology, Section of Radiotherapy, Rigshospitalet, University of Copenhagen, Denmark; Department of Hematology, Rigshospitalet, University of Copenhagen, Denmark.
Abstract
INTRODUCTION: Reconstruction of radiotherapy (RT) performed decades ago is challenging, but is necessary to address dose-response questions from epidemiological data and may be relevant in re-irradiation scenarios. Here, a novel method to reconstruct extended and involved field RT for patients with Hodgkin lymphoma was used. MATERIALS AND METHODS: For 46 model patients, 29 organs at risk (OARs) were contoured and seven treatment fields reconstructed (mantle, mediastinal, right/left neck, right/left axillary, and spleen field). Extended and involved field RT were simulated by generating RT plans by superpositions of the seven individual fields. The mean (standard deviation) of the 46 individual mean organ doses were extracted as percent of prescribed dose for each field superposition. RESULTS: The estimated mean doses to the OARs from 17 field combinations were presented. The inter-patient variability was found to be a larger contributor to the uncertainty than the field simulation process. The inter-patient variability depended on the OAR and primarily affected the estimates for OARs located at the edge of the RT field. CONCLUSIONS: Dose estimates for 29 OARs were reported from extended and involved field RT. These estimates could be employed when individual reconstruction is not feasible and estimated doses from past treatments are needed.
INTRODUCTION: Reconstruction of radiotherapy (RT) performed decades ago is challenging, but is necessary to address dose-response questions from epidemiological data and may be relevant in re-irradiation scenarios. Here, a novel method to reconstruct extended and involved field RT for patients with Hodgkin lymphoma was used. MATERIALS AND METHODS: For 46 model patients, 29 organs at risk (OARs) were contoured and seven treatment fields reconstructed (mantle, mediastinal, right/left neck, right/left axillary, and spleen field). Extended and involved field RT were simulated by generating RT plans by superpositions of the seven individual fields. The mean (standard deviation) of the 46 individual mean organ doses were extracted as percent of prescribed dose for each field superposition. RESULTS: The estimated mean doses to the OARs from 17 field combinations were presented. The inter-patient variability was found to be a larger contributor to the uncertainty than the field simulation process. The inter-patient variability depended on the OAR and primarily affected the estimates for OARs located at the edge of the RT field. CONCLUSIONS: Dose estimates for 29 OARs were reported from extended and involved field RT. These estimates could be employed when individual reconstruction is not feasible and estimated doses from past treatments are needed.
Authors: Daniel Gasic; Per Munck Af Rosenschöld; Ivan R Vogelius; Maja V Maraldo; Marianne C Aznar; Karsten Nysom; Thomas Björk-Eriksson; Søren M Bentzen; Nils Patrik Brodin Journal: Radiother Oncol Date: 2018-05-30 Impact factor: 6.280
Authors: Nicola S Russell; Inge M Krul; Anna M van Eggermond; Berthe M P Aleman; Rosie Cooke; Susanne Kuiper; Steven D Allen; Matthew G Wallis; Damien Llanas; Ibrahima Diallo; Florent de Vathaire; Susan A Smith; Michael Hauptmann; Annegien Broeks; Anthony J Swerdlow; Flora E Van Leeuwen Journal: Clin Transl Radiat Oncol Date: 2017-10-24
Authors: David J Cutter; Johanna Ramroth; Patricia Diez; Andy Buckle; Georgios Ntentas; Bilyana Popova; Laura Clifton-Hadley; Peter J Hoskin; Sarah C Darby; John Radford; Tim Illidge Journal: J Clin Oncol Date: 2021-08-13 Impact factor: 50.717
Authors: David A Jones; Paolo Candio; Rebecca Shakir; Georgios Ntentas; Johanna Ramroth; Alastair M Gray; David J Cutter Journal: Blood Adv Date: 2022-02-08